PharmacovigilanceOfficial

CMS finalises CY 2027 Physician Fee Schedule, citing prevention focus and waste reduction

🇺🇸 CMS · Wed 04 Nov 2026

The US agency says the final rule moves Medicare payment emphasis towards preventive care and away from treating illness, while curbing waste; provision-level detail is not yet clear.

The US Centers for Medicare & Medicaid Services (CMS) has finalised the Medicare Physician Fee Schedule for calendar year 2027. The announcement is dated 4 November 2026.

In its press release, the agency describes the rule as shifting payment emphasis from treating illness towards preventive healthcare, and as a means of curbing waste.

The material available to VigiEye contains no detail on specific provisions, such as payment rates, policy changes or implementation dates. The practical effect on pharmaceutical companies, device makers or pharmacovigilance activities cannot yet be judged.

By way of context, the Physician Fee Schedule is the annual Medicare rule that sets payment for services delivered by physicians and certain other practitioners. Its effects depend on the final rule text.

What it means for your team

  • Market-access teams should read the final rule text before assessing any effect on physician-administered products, services or care pathways.
  • The press release states a general policy direction, towards prevention and waste reduction, but gives no provision-level detail to act on.
  • Regulatory and PV teams should not infer any compliance or reporting change until specific provisions are confirmed.

Official source: CMS ↗

Article written by VigiEye from the official source (CMS). AI-assisted; check the source before acting.

More Pharmacovigilance All →